Taylor Grim is an accomplished finance professional with extensive experience in the pharmaceutical industry. Currently serving as the Director of US Commercial Finance at Genentech since July 2018, Taylor leads commercial finance for immunology, lytics, and established products while also overseeing the MBA Intern Program. Prior roles at Genentech include Senior Finance Manager, providing finance support for ophthalmology and foundational products, and participation in a finance rotational development program with experiences in various financial areas across the US and internationally. Taylor's previous experience includes roles as a Corporate Finance MBA Summer Associate at Genentech and as a Financial Analyst for Blount County Government. Educational credentials include an MBA from Vanderbilt University's Owen Graduate School of Management and dual Bachelor's degrees in Finance and Economics from Wofford College.